182 related articles for article (PubMed ID: 11815968)
21. Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival.
Johnson GA; Mannel R; Khalifa M; Walker JL; Wren M; Min KW; Benbrook DM
Gynecol Oncol; 1997 Jun; 65(3):425-9. PubMed ID: 9190969
[TBL] [Abstract][Full Text] [Related]
22. Expression of CD44 variant isoforms, CD44v3 and CD44v6, are associated with prognosis in nasopharyngeal carcinoma.
Sagawa K; Uwa N; Daimon T; Sakagami M; Tsujimura T
J Laryngol Otol; 2016 Sep; 130(9):843-9. PubMed ID: 27453283
[TBL] [Abstract][Full Text] [Related]
23. Cytokine, cell adhesion receptor, and tumor suppressor gene expression in vulvar squamous carcinoma: correlation with prominent fibromyxoid stromal response.
Ambros RA; Kallakury BV; Malfetano JH; Mihm MC
Int J Gynecol Pathol; 1996 Oct; 15(4):320-5. PubMed ID: 8886879
[TBL] [Abstract][Full Text] [Related]
24. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H
Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789
[TBL] [Abstract][Full Text] [Related]
25. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
26. CD44v6 as a prognostic factor in cervical carcinoma FIGO stage IB.
Bouda J; Boudova L; Hes O; Havir M; Tempfer C; Kohlberger P; Svoboda T; Rokyta Z; Speiser P
Anticancer Res; 2005; 25(1B):617-22. PubMed ID: 15816636
[TBL] [Abstract][Full Text] [Related]
27. CD44 variant 6 in endometrioid carcinoma of the uterus: its expression in the adenocarcinoma component is an independent prognostic marker.
Hoshimoto K; Yamauchi N; Takazawa Y; Onda T; Taketani Y; Fukayama M
Pathol Res Pract; 2003; 199(2):71-7. PubMed ID: 12747468
[TBL] [Abstract][Full Text] [Related]
28. CD44V6 expression in human colorectal carcinoma.
Coppola D; Hyacinthe M; Fu L; Cantor AB; Karl R; Marcet J; Cooper DL; Nicosia SV; Cooper HS
Hum Pathol; 1998 Jun; 29(6):627-35. PubMed ID: 9635685
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer.
Tempfer C; Lösch A; Heinzl H; Häusler G; Hanzal E; Kölbl H; Breitenecker G; Kainz C
Eur J Cancer; 1996 Oct; 32A(11):2023-5. PubMed ID: 8943691
[TBL] [Abstract][Full Text] [Related]
30. Expression of human chorionic gonadotropin, CD44v6 and CD44v4/5 in esophageal squamous cell carcinoma.
Li DM; Li SS; Zhang YH; Zhang HJ; Gao DL; Wang YX
World J Gastroenterol; 2005 Dec; 11(47):7401-4. PubMed ID: 16437708
[TBL] [Abstract][Full Text] [Related]
31. EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction.
Oonk MH; de Bock GH; van der Veen DJ; Ten Hoor KA; de Hullu JA; Hollema H; van der Zee AG
Gynecol Oncol; 2007 Jan; 104(1):109-13. PubMed ID: 16963112
[TBL] [Abstract][Full Text] [Related]
32. CD44 loss in gastric stromal tumors as a prognostic marker.
Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A
Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305
[TBL] [Abstract][Full Text] [Related]
33. Effect of c-Met and CD44v6 Expression in Resistance to Chemotherapy in Esophageal Squamous Cell Carcinoma.
Hara T; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Matsuura N; Mori M; Doki Y
Ann Surg Oncol; 2019 Mar; 26(3):899-906. PubMed ID: 30610559
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: a meta-analysis.
Zhao S; He JL; Qiu ZX; Chen NY; Luo Z; Chen BJ; Li WM
Asian Pac J Cancer Prev; 2014; 15(16):6761-6. PubMed ID: 25169522
[TBL] [Abstract][Full Text] [Related]
35. p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomas.
Knopp S; Bjørge T; Nesland JM; Tropé C; Scheistrøen M; Holm R
Gynecol Oncol; 2004 Oct; 95(1):37-45. PubMed ID: 15385108
[TBL] [Abstract][Full Text] [Related]
36. Expression of human CD44v6 in non-small-cell lung cancer.
Carbognani P; Spaggiari L; Romani A; Solli P; Corradi A; Cantoni AM; Petronini PG; Borghetti AF; Rusca M; Bobbio P
Eur Surg Res; 1998; 30(6):403-8. PubMed ID: 9838232
[TBL] [Abstract][Full Text] [Related]
37. Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma.
Yokoyama Y; Hiyama E; Murakami Y; Matsuura Y; Yokoyama T
Cancer; 1999 Nov; 86(9):1691-9. PubMed ID: 10547541
[TBL] [Abstract][Full Text] [Related]
38. CD44v6 expression in primary breast carcinoma in western India: a pilot clinicopathologic study.
Shah NG; Trivedi TI; Vora HH; Patel KC; Tankshali R; Goswami JV; Shukla SN; Shah PM
Tumori; 2010; 96(6):971-7. PubMed ID: 21388061
[TBL] [Abstract][Full Text] [Related]
39. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
Tran TA; Kallakury BV; Sheehan CE; Ross JS
Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
[TBL] [Abstract][Full Text] [Related]
40. Mortality association of enhanced CD44v6 expression is not mediated through occult lymphatic spread in stage II colorectal cancer.
Clarke G; Ryan E; O'Keane JC; Crowe J; Mathúna PM
J Gastroenterol Hepatol; 2000 Sep; 15(9):1028-31. PubMed ID: 11059932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
